Watch out for Jim Grierson and Dr Jian Guan
TV1 on or around February 27th.

Brain-Shield

Last month, we told you about the research findings of Dr Jian Guan and the team of clinical doctors at New Zealand universities. Jim Grierson of Vitality®New Zealand has advised us that they will be announcing the results of this important research on the 27th, and launching the new product Brain Shield™ that has been developed, using New Zealand blackcurrants.

 

Details from last month's newsletter

The extensive research results from scientists and clinical doctors in New Zealand Universities, demonstrate that a key brain nutrient in New Zealand blackcurrants [cyclic Glycine-Proline (cGP)] is beneficial in regulating and maintaining the normal function of hormones that would usually decline with ageing. This discovery has major significance for the ageing body and mind, particularly in relation to cognitive function. New Zealand Blackcurrants naturally contain a high level of this nutrient. During our lifetime, our bodies produce the key nutrient naturally. As we get older, however, the function of this key nutrient can become insufficient. People diagnosed with cognitive impairment, hypertension and strokes all show deficits of this key nutrient. Research results Pre-clinical research suggests that giving additional key nutrient can improve cognitive function, reduce blood pressure and improve stroke recovery. Clinical research into Parkinson diseases also shows that the supplementation of New Zealand Blackcurrants can increase the key nutrient in the blood and brain.Content goes here

Research results

Dr-Jian-Guan

Pre-clinical research suggests that giving additional key nutrient can improve cognitive function, reduce blood pressure and improve stroke recovery. Clinical research into Parkinson diseases also shows that the supplementation of New Zealand Blackcurrants can increase the key nutrient in the blood and brain.

The website brainshield.co.nz will be ‘live’ on February 27th.

And a huge Thank You to the readers who have been taking part in the recent trial. Jim Grierson is delighted with the feedback you have been sending him and we will bring you some of the results next month.